Druce, Julian D.

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.

Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020) · Antiviral Research

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 2,179

Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial

Writing Committee for the REMAP-CAP Investigators, Abdelhady, H., Abdelrazik, M., Abdi, Z., Abdo, D., Abdulle, A., Abel, L., Abouzeenni, S., Abrahamson, G., Abusamra, Y., et al. (2021) · JAMA

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 212

A Quantitative Assessment of the Efficacy of Surgical and N95 Masks to Filter Influenza Virus in Patients with Acute Influenza Infection

Johnson, D. F., Druce, J. D., Birch, C., & Grayson, M. L. (2009) · Clinical Infectious Diseases

Infection Control and VentilationInfluenza Virus Research Studies

Cited by 211

Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19.

Moore, S. C., Penrice-Randal, R., Alruwaili, M., Dong, X., Pullan, S. T., Carter, D. P., Bewley, K., Zhao, Q., Sun, Y., Hartley, C., et al. (2020) · Viruses

SARS-CoV-2 detection and testingSARS-CoV-2 and COVID-19 Research

Cited by 121

Sepsis-like Disease in Infants Due to Human Parechovirus Type 3 During an Outbreak in Australia

Khatami, A., McMullan, B. J., Webber, M., Stewart, P., Francis, S., Timmers, K. J., Rodas, E., Druce, J., Mehta, B., Sloggett, N. A., et al. (2015) · Clinical Infectious Diseases

Viral Infections and Immunology ResearchRespiratory viral infections research

Cited by 119

At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant

Singanallur, N. B., van Vuren, P. J., McAuley, A. J., Bruce, M. P., Kuiper, M. J., Gwini, S. M., Riddell, S., Goldie, S., Drew, T. W., Blasdell, K. R., et al. (2022) · Frontiers in Immunology

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 15

At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant

Singanallur, N. B., van Vuren, P. J., McAuley, A. J., Bruce, M. P., Kuiper, M. J., Gwini, S. M., Riddell, S., Goldie, S., Drew, T. W., Blasdell, K. R., et al. (2022) · Frontiers in Immunology

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 15

Highly Thermotolerant SARS-CoV-2 Vaccine Elicits Neutralising Antibodies Against Delta and Omicron in Mice

van Vuren, P. J., McAuley, A. J., Kuiper, M. J., Singanallur, N. B., Bruce, M. P., Riddell, S., Goldie, S., Mangalaganesh, S., Chahal, S., Drew, T. W., et al. (2022) · Viruses

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 9